Literature DB >> 2782757

International comparisons in COPD mortality.

T J Thom1.   

Abstract

In 31 developed countries, chronic obstructive pulmonary disease (COPD) and allied conditions comprise a major cause of death, but they cause less than 10% of all deaths, even in older persons. COPD mortality is highest in the Eastern European countries and Ireland, Scotland, and England/Wales, and is lowest in southern Europe, Japan, and Israel. That these differences are large and real is a likelihood but not a certainty, due to problems in comparability of cause-of-death statistics. In the past, the trend in COPD mortality has been upwards. Over the short time period of 1980 to 1985, there have been substantial declines in death rates in most countries for the major causes of death, but not for COPD or lung cancer. It is not clear, however, whether COPD mortality is continuing to increase everywhere. In only nine countries is the trend upwards and only in women above age 55 and in men above age 75. In the other 22 countries, trends are not clearly upwards or downwards. Longer time trend statistics are needed to corroborate and explain these patterns and the apparent intercountry differences.

Entities:  

Mesh:

Year:  1989        PMID: 2782757     DOI: 10.1164/ajrccm/140.3_Pt_2.S27

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

Review 1.  Gender differences in airway behaviour over the human life span.

Authors:  M R Becklake; F Kauffmann
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

2.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.

Authors:  N Yamada; M Yamaya; S Okinaga; K Nakayama; K Sekizawa; S Shibahara; H Sasaki
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.

Authors:  C Fuhrman; E Jougla; J Nicolau; D Eilstein; M-C Delmas
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

4.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

5.  Inhaled corticosteroids in COPD: awaiting controlled trials.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

6.  Lies, damned lies and mortality statistics?

Authors:  A L Hansell
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

7.  Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease.

Authors:  C A Brown; I K Crombie; H Tunstall-Pedoe
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

8.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents.

Authors:  P S Bakke; V Baste; R Hanoa; A Gulsvik
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

9.  An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.

Authors:  R de Marco; S Accordini; I Cerveri; A Corsico; J Sunyer; F Neukirch; N Künzli; B Leynaert; C Janson; T Gislason; P Vermeire; C Svanes; J M Anto; P Burney
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

10.  Asthma and chronic bronchitis. Can family physicians predict rates of progression?

Authors:  C P van Schayck; E Dompeling; R Putters; J Molema; C van Weel
Journal:  Can Fam Physician       Date:  1995-11       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.